Melanoma Therapeutic Strategies That Select Against Resistance by Exploiting MYC-Driven Evolutionary Convergence
Katherine R. Singleton(Duke University), Kris C. Wood(Duke University), Anniefer N. Magpusao(Case Western Reserve University), Genevieve M. Boland(Harvard University), Haley E. Manchester(Brigham and Women's Hospital), Sayan Mukherjee(Duke University), Elizabeth Tsu(Duke University), Keith T. Flaherty(Cancer Research Center), Drew Adams(University School), Meenhard Herlyn(The Wistar Institute), Lorin Crawford(Microsoft (United States)), Clemens Krepler(Merck & Co., Inc., Rahway, NJ, USA (United States)), Shannon J. McCall(Duke Medical Center), Dennie T. Frederick(Broad Institute), Jason W. Locasale(Duke University), Katrin Sproesser(The Wistar Institute), Elizabeth M. Stein(Duke University), Ophélia Maertens(American Institutes for Research), Jennifer P. Tingley(Duke University), Karen Cichowski(Brigham and Women's Hospital), Xiaojing Liu(Duke University), Maria V. Liberti(Duke University)
Cited by 6
Related Papers
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
|Proceedings of the National Academy of Sciences|2005|56.5k
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
|Science|2016|5.3k
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
|New England Journal of Medicine|2010|3.5k
Choosing Multiple Parameters for Support Vector Machines
|Machine Learning|2002|2.2k